Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Sparsentan in Patients With Primary Focal Segmental Glomerulosclerosis (FSGS)

ClinicalTrials.gov ID: NCT03493685

Public ClinicalTrials.gov record NCT03493685. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 5:48 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Double-blind, Parallel, Active-control Study of the Effects of Sparsentan, a Dual Endothelin Receptor and Angiotensin Receptor Blocker, on Renal Outcomes in Patients With Primary FSGS

Study identification

NCT ID
NCT03493685
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Travere Therapeutics, Inc.
Industry
Enrollment
371 participants

Conditions and interventions

Interventions

  • sparsentan Drug
  • Irbesartan Drug

Drug

Eligibility (public fields only)

Age range
8 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 16, 2018
Primary completion
Mar 19, 2023
Completion
Mar 18, 2026
Last update posted
Apr 16, 2026

2018 – 2026

United States locations

U.S. sites
87
U.S. states
33
U.S. cities
76
Facility City State ZIP Site status
Travere Investigational Site Mesa Arizona 85210
Travere Investigational Site Phoenix Arizona 85027
Travere Investigational Site Los Angeles California 90048
Travere Investigational Site Northridge California 91324
Travere Investigational Site Palo Alto California 94304
Travere Investigational Site San Diego California 92103
Travere Investigational Site San Dimas California 91773
Travere Investigational Site San Francisco California 94118
Travere Investigational Site Torrance California 90502
Travere Investigational Site Victorville California 92395
Travere Investigational Site Denver Colorado 80205
Travere Investigational Site Denver Colorado 80230
Travere Investigational Site Middlebury Connecticut 06762
Travere Investigational Site Wilmington Delaware 19803
Travere Investigational Site Washington D.C. District of Columbia 20010
Travere Investigational Site Coral Springs Florida 33071
Travere Investigational Site Fort Lauderdale Florida 33308
Travere Investigational Site Gainesville Florida 32610
Travere Investigational Site Miami Florida 33126
Travere Investigational Site Miami Florida 33136
Travere Investigational Site Miami Florida 33155
Travere Investigational Site Ocala Florida 34471
Travere Investigational Site Orlando Florida 32827
Travere Investigational Site Port Charlotte Florida 33952
Travere Investigational Site Temple Terrace Florida 33637
Travere Investigational Site Winter Park Florida 32789
Travere Investigational Site Lawrenceville Georgia 30046
Travere Investigational Site Nampa Idaho 86387
Travere Investigational Site Chicago Illinois 60611
Travere Investigational Site Hinsdale Illinois 60521
Travere Investigational Site Kansas City Kansas 66160
Travere Investigational Site Wichita Kansas 67214
Travere Investigational Site Louisville Kentucky 40202
Travere Investigational Site Monroe Louisiana 71201
Travere Investigational Site New Orleans Louisiana 70121
Travere Investigational Site Shreveport Louisiana 71101
Travere Investigational Site Boston Massachusetts 02111
Travere Investigational Site Springfield Massachusetts 01107
Travere Investigational Site Ann Arbor Michigan 48109
Travere Investigational Site Detroit Michigan 48202
Travere Investigational Site Minneapolis Minnesota 55404
Travere Investigational Site Minneapolis Minnesota 55455
Travere Investigational Site Rochester Minnesota 55902
Travere Investigational Site Kansas City Missouri 64108
Travere Investigational Site Kansas City Missouri 64111
Travere Investigational Site Las Vegas Nevada 89129
Travere Investigational Site Reno Nevada 89511
Travere Investigational Site Hackensack New Jersey 07601
Travere Investigational Site Fresh Meadows New York 11365
Travere Investigational Site New Hyde Park New York 11040
Travere Investigational Site New York New York 10016
Travere Investigational Site New York New York 10029
Travere Investigational Site New York New York 10032
Travere Investigational Site The Bronx New York 10467
Travere Investigational Site Chapel Hill North Carolina 27514
Travere Investigational Site Durham North Carolina 27710
Travere Investigational Site Raleigh North Carolina 27609
Travere Investigational Site Winston-Salem North Carolina 27103
Travere Investigational Site Cleveland Ohio 44195
Travere Investigational Site Columbus Ohio 43210
Travere Investigational Site Oklahoma City Oklahoma 73104
Travere Investigational Site Roseburg Oregon 97471
Travere Investigational Site Bethlehem Pennsylvania 18017
Travere Investigational Site Camp Hill Pennsylvania 17011
Travere Investigational Site Philadelphia Pennsylvania 19104
Travere Investigational Site Pittsburgh Pennsylvania 15224
Travere Investigational Site Upland Pennsylvania 19013
Travere Investigational Site Columbia South Carolina 29203
Travere Investigational Site Memphis Tennessee 38103
Travere Investigational Site Corpus Christi Texas 78412
Travere Investigational Site Dallas Texas 75231
Travere Investigational Site Dallas Texas 75235
Travere Investigational Site Dallas Texas 75246
Travere Investigational Site El Paso Texas 79902
Travere Investigational Site Fort Worth Texas 76104
Travere Investigational Site Houston Texas 77030
Travere Investigational Site Houston Texas 77054
Travere Investigational Site Lewisville Texas 75057
Travere Investigational Site Sherman Texas 75090
Travere Investigational Site Salt Lake City Utah 84112
Travere Investigational Site Salt Lake City Utah 84115
Travere Investigational Site St. George Utah 84790
Travere Investigational Site Hampton Virginia 23666
Travere Investigational Site Spokane Washington 99204
Travere Investigational Site Morgantown West Virginia 26506
Travere Investigational Site Marshfield Wisconsin 54449
Travere Investigational Site Wauwatosa Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 139 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03493685, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 16, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03493685 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →